Literature DB >> 20707604

Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.

Rolf Mentlein1, Kirsten Hattermann, Charles Hemion, Achim A Jungbluth, Janka Held-Feindt.   

Abstract

Seprase or fibroblast activation protein-α (FAP-α) is a cell-surface serine protease that was previously described nearly exclusively on reactive and tumor stromal fibroblasts and thought to be involved in tissue remodeling. We investigated the expression and significance of FAP-α in astrocytomas/glioblastomas. As shown by quantitative reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry, FAP-α was elevated in whole glioblastoma tissues and in particular in most glioma cells in situ and in vitro. In glioma stem-like cells (gliospheres), FAP-α was detected at low levels; however, FAP-α was considerably induced upon differentiation with 10% fetal calf serum. To explore its functional role, FAP-α was silenced by siRNA transfection. In Boyden chamber assays, FAP-α silenced cells migrated similar as control cells through non-coated or Matrigel (basal lamina)-coated porous membranes, but significantly slower through membranes coated with gelatin or brevican, a major component of brain extracellular matrix. Furthermore, FAP-α-silenced glioma cells migrated through murine brain slices much slower under the conditions tested than differentially fluorescent-labeled control cells. Thus, FAP-α is highly expressed on the surface of glioma cells and contributes to diffuse glioma invasion through extracellular matrix components.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20707604     DOI: 10.1515/BC.2010.119

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  24 in total

1.  Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma.

Authors:  Mengzhen Zhang; Liwei Xu; Xiaoling Wang; Beibei Sun; Juan Ding
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

Review 2.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

3.  Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.

Authors:  Petr Busek; Eva Balaziova; Ivana Matrasova; Marek Hilser; Robert Tomas; Martin Syrucek; Zuzana Zemanova; Evzen Krepela; Jaromir Belacek; Aleksi Sedo
Journal:  Tumour Biol       Date:  2016-08-04

4.  Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.

Authors:  Fu-Ming Zi; Jing-Song He; Yi Li; Cai Wu; Wen-Jun Wu; Yang Yang; Li-Juan Wang; Dong-Hua He; Li Yang; Yi Zhao; Gao-Feng Zheng; Xiao-Yan Han; He Huang; Qing Yi; Zhen Cai
Journal:  Cancer Biol Ther       Date:  2014-07-21       Impact factor: 4.742

5.  Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells.

Authors:  Eva Balaziova; Petr Busek; Jarmila Stremenova; Lucie Sromova; Evzen Krepela; Libuse Lizcova; Aleksi Sedo
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

6.  Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways.

Authors:  Chao Zeng; Ming Wen; Xiaomei Liu
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

7.  Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.

Authors:  Sunitha Kakarla; Kevin K H Chow; Melinda Mata; Donald R Shaffer; Xiao-Tong Song; Meng-Fen Wu; Hao Liu; Lisa L Wang; David R Rowley; Klaus Pfizenmaier; Stephen Gottschalk
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

8.  IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Authors:  Manuel Röhrich; Anastasia Loktev; Annika K Wefers; Annette Altmann; Daniel Paech; Sebastian Adeberg; Paul Windisch; Thomas Hielscher; Paul Flechsig; Ralf Floca; Dominik Leitz; Julius P Schuster; Peter E Huber; Jürgen Debus; Andreas von Deimling; Thomas Lindner; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

Review 9.  Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.

Authors:  Yixin Shi; Ziren Kong; Penghao Liu; Guozhu Hou; Jiaming Wu; Wenbin Ma; Xin Cheng; Yu Wang
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

10.  Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.

Authors:  Fiona M Keane; Tsun-Wen Yao; Stefanie Seelk; Margaret G Gall; Sumaiya Chowdhury; Sarah E Poplawski; Jack H Lai; Youhua Li; Wengen Wu; Penny Farrell; Ana Julia Vieira de Ribeiro; Brenna Osborne; Denise M T Yu; Devanshi Seth; Khairunnessa Rahman; Paul Haber; A Kemal Topaloglu; Chuanmin Wang; Sally Thomson; Annemarie Hennessy; John Prins; Stephen M Twigg; Susan V McLennan; Geoffrey W McCaughan; William W Bachovchin; Mark D Gorrell
Journal:  FEBS Open Bio       Date:  2013-12-08       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.